Tatva Chintan Pharma Chem Ltd. (TATVA) 52 Week High Streak: Consecutive High Analysis

Tatva Chintan Pharma Chem Ltd. has now set a fresh 52-week high for its second straight session, with the stock moving 4.42% across the streak and touching a new one-year peak of Rs 2,001. The latest traded price was Rs 1,967.35 at 08 October 2026 at 9:22 AM IST. The pattern is clear, but the latest figures do not establish a company-specific catalyst for the repeated highs.

The stock’s previous close was Rs 1,994.50, while the day opened at Rs 1,995.25 and moved between Rs 1,953.75 and Rs 2,001.00. Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,407.41 crore. For readers, a repeated 52 Week High Streak is different from a one-off breakout because it shows the stock has kept revisiting a higher price area across more than one trading session.

Tatva Chintan Pharma Chem Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 1,967.35
Previous Close	Rs 1,994.5
Today's Move	Rs -27.15 (-1.36%)
Open	Rs 1,995.25
High	Rs 2,001
Low	Rs 1,953.75
Market Capitalisation	Rs 4,407.41 crore

Tatva Chintan Pharma Chem Ltd. (TATVA) traded at Rs 1,967.35 versus the previous close of Rs 1,994.5, a fall of 1.36%. The stock opened at Rs 1,995.25, reached a high of Rs 2,001 and touched a low of Rs 1,953.75.

Tatva Chintan Pharma Chem Ltd. share price today was Rs 1,967.35, down Rs 27.15 or 1.36% versus the previous close of Rs 1,994.50. Even with that intraday softness, the stock still printed a fresh 52-week high at Rs 2,001.00, which is the latest reference point for the Tatva Chintan Pharma Chem Ltd. 52 Week High Streak. The day opened at Rs 1,995.25 and the stock moved between Rs 1,953.75 and Rs 2,001.00, placing the latest traded price in the lower part of the range. Market capitalisation stood at Rs 4,407.41 crore. In a Tatva Chintan Pharma Chem Ltd. Share Price Update, the important point is not just the day’s change, but that the stock has now built a repeated-high pattern across consecutive sessions.

Tatva Chintan Pharma Chem Ltd. 52 Week High Streak: Consecutive High Analysis

Tatva Chintan Pharma Chem Ltd. 52 Week High Streak now extends into a second straight session, and the cumulative move across that stretch is 4.42%. The current 52-week high of Rs 2,001.00 is the level that marks the latest peak in the streak, and it now stands above the prior session’s fresh one-year high reached on 07 October 2026. That is the key differentiator in a Tatva Chintan Pharma Chem Ltd. 52 Week High Streak article: the story is not just that the stock reached a new high once, but that it has kept doing so on back-to-back sessions.

The consecutive pattern matters because it gives readers a fuller view of the move than a single-day breakout can provide. In a Tatva Chintan Pharma Chem Ltd. 52 Week High Streak, the cumulative percentage across the run becomes the central figure, while the latest peak shows how far the stock has continued to extend its one-year range. The latest trading number was still below the peak, which means the market was pricing the stock beneath the day’s high at the time of writing. The latest Univest figures confirm the repeated-high pattern, but they do not show why the stock has kept printing new highs.

What the Repeated 52-Week Highs Show

The Tatva Chintan Pharma Chem Ltd. 52 Week High Streak shows a stock that has continued to reset its one-year peak across consecutive trading sessions, while the latest trading price stayed below the intraday high. For investors tracking Tatva Chintan Pharma Chem Ltd. Stock Performance, the useful takeaway is that the current move is measured by the full streak, not only by the latest session’s percentage change. The cumulative 4.42% advance across the streak is the figure that captures the combined effect of the repeated highs.

This repeated-high pattern also helps separate a streak from a one-session headline. Tatva Chintan Pharma Chem Ltd. New One Year High again means the stock has crossed into fresh territory more than once in a row, and that makes the current one-year range more relevant than the single day’s price change. The latest figures confirm the pattern, but they do not identify a company-specific reason for the continued move. That is important for readers comparing Tatva Chintan Pharma Chem Ltd. Back To Back 52 Week Highs with other Stocks Hitting 52 Week Highs or Stocks At One Year High Today.

Tatva Chintan Pharma Chem Ltd. (TATVA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 4,407.41 crore
P/E Ratio	90.8x
P/B Ratio	5.85x
ROE	5.53%
ROCE	7.17%
EPS	Rs 21.97
Book Value Per Share	Rs 341.03
Dividend Yield	0.1%

Tatva Chintan Pharma Chem Ltd. (TATVA) fundamental metrics show P/E 90.8x, P/B 5.85x, ROE 5.53%, ROCE 7.17%. Read together, these ratios describe the company's position rather than a recommendation.

Tatva Chintan Pharma Chem Ltd. has a market capitalisation of Rs 4,407.41 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 90.8x, P/B at 5.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.53% and ROCE of 7.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 21.97, book value per share of Rs 341.03, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.81x, median ROE of 7.87%, median ROCE of 10.04%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Chemicals
Industry	Chemicals
Benchmark Scope	same industry
Company P/E Ratio	90.8x
Benchmark Median P/E	26.81x
Benchmark Average P/E	50.5x
Benchmark P/E Range	5.07x to 727.27x
Company P/B Ratio	5.85x
Benchmark Median P/B	2.05x
Company ROE	5.53%
Benchmark Median ROE	7.87%
Company ROCE	7.17%
Benchmark Median ROCE	10.04%
Company Market Capitalisation	Rs 4,407.41 crore
Benchmark Median Market Cap	Rs 482.6 crore

Tatva Chintan Pharma Chem Ltd. (TATVA) operates in the Chemicals sector, within the Chemicals industry.

Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 90.8x, which is above the benchmark median of 26.81x, a difference of +238.68%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROE of 5.53%, which is below the benchmark median of 7.87%, a difference of -29.73%. Tatva Chintan Pharma Chem Ltd. (TATVA) has a ROCE of 7.17%, which is below the benchmark median of 10.04%, a difference of -28.59%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Epigral Ltd.	EPIGRAL	4,476.35	16.4	1.92	16.09	15.65
Gujarat Alkalies And Chemicals Ltd.	GUJALKALI	4,526.29	68.15	0.86	-0.04	1.4
Vishnu Chemicals Ltd.	VISHNU	4,675.38	30.74	4.15	14.26	16.38
Foseco India Ltd.	FOSECOIND	4,862.47	66.42	4.45	10.87	15.35
GHCL Ltd.	GHCL	3,767.68	7.77	1.04	13.46	18.12

Tatva Chintan Pharma Chem Ltd. (TATVA) has a P/E ratio of 90.8x compared with the displayed peer median of 30.74x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 5.53% compares with a peer median of 13.46% across the companies shown in the table. ROCE stood at 7.17% versus the displayed peer median of 15.65%, providing a capital-efficiency comparison. Tatva Chintan Pharma Chem Ltd. (TATVA) has a market capitalisation of Rs 4,407.41 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Tatva Chintan Pharma Chem Ltd.

• The stock has now set a fresh 52-week high for a second straight session, which defines the Tatva Chintan Pharma Chem Ltd. 52 Week High Streak.
• The cumulative move across the streak is 4.42%, which is the key figure for tracking the repeated-high pattern.
• The latest 52-week high of Rs 2,001.00 is above the previous one-year peak from the prior session.
• The current P/E ratio of 90.8 and P/B ratio of 5.85 place the stock well above the Chemicals medians.
• ROE of 5.53% and ROCE of 7.17% provide the operating context investors can compare against the streak-driven price move.

About Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd. operates in the Chemicals sector and the Chemicals industry, with a market capitalisation of Rs 4,407.41 crore. The company’s stock on NSE and BSE is now in the spotlight because of the Tatva Chintan Pharma Chem Ltd. 52 Week High Streak, but the business context remains important: investors are viewing a higher-priced equity against a backdrop of modest return ratios, a premium valuation and a market cap that is close to several listed chemical peers.

For readers following Tatva Chintan Pharma Chem Ltd. Stock News or Tatva Chintan Pharma Chem Ltd. Stock Performance, the main business point is that the company is being assessed within the Chemicals space, where peer valuations, profitability and market capitalisation all shape how the streak is interpreted.

Track Tatva Chintan Pharma Chem Ltd. on Univest

Track Tatva Chintan Pharma Chem Ltd. Share Price on Univest to follow the latest traded price, the fresh 52-week high and the next market move. If the Tatva Chintan Pharma Chem Ltd. 52 Week High Streak continues, the cumulative rise, valuation and sector comparison will remain the main markers to watch.

Frequently Asked Questions

What is the Tatva Chintan Pharma Chem Ltd. 52 Week High Streak?

Ans. It means Tatva Chintan Pharma Chem Ltd. has set a fresh 52-week high for two consecutive trading sessions. The latest streak figure is 4.42%, and the current peak is Rs 2,001.00.

How many sessions has the stock set a fresh yearly high?

Ans. The stock has set a fresh 52-week high for a second straight session. That is the defining pattern behind the Tatva Chintan Pharma Chem Ltd. 52 Week High Streak.

What is the cumulative move across the streak?

Ans. The cumulative move across the streak is 4.42%. That figure captures the full repeated-high run rather than only the latest session’s price change.

How does the current high compare with the previous one?

Ans. The current 52-week high is Rs 2,001.00, and it is higher than the prior session’s one-year peak. That makes this a back-to-back high pattern rather than a single breakout.

What was the latest traded price?

Ans. The latest traded price was Rs 1,967.35 at 08 October 2026 at 9:22 AM IST. It was below the day’s high and below the fresh 52-week peak.

What were the day’s open, high and low?

Ans. The stock opened at Rs 1,995.25, touched a high of Rs 2,001.00 and a low of Rs 1,953.75. Those levels frame the latest intraday range for the streak session.

How is Tatva Chintan Pharma Chem Ltd. valued?

Ans. The stock is trading at a P/E of 90.8 and a P/B of 5.85. Both measures are well above the Chemicals sector medians in the displayed comparison set.

How does the stock compare with Chemicals peers?

Ans. It trades at a much higher P/E and P/B than most peers shown, including Epigral, Vishnu Chemicals, GHCL and Styrenix. Its returns on equity and capital employed are below several of those names.